Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Treu Jesse I
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   55,258    

Indirect Shares

  2,983,502      
Direct Value   $35,301    

Indirect Value

  $11,057,209      
Total Shares   3,038,760      
Total Value   $11,092,510      


Northstar Neuroscience Inc
 $0 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $80 Veracyte, Inc.
 $35,221 Northstar Neuroscience Inc
 $0 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $80 Veracyte, Inc.
 $35,221
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director 2010-06-09 0 2009-12-18 0    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR Director 2007-05-18 17,231 2007-05-18 14,690    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 21,289 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 15,096 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA Director, 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT Director 2019-03-04 1,642 2019-03-04 1,641    Premium*  
            Tandem Diabetes Care Inc TNDM Director, 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX Director 2019-03-26 0 2019-03-26 8,763    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-12-12 4 S $25.62 $330,498 I/I (12,900) 21,068 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2007-06-01 4 S $20.59 $600,940 D/D (29,186) 0 0 -
VCYT Veracyte, Inc. Director   –       •      –    2019-03-01 4 S $20.45 $5,623,750 I/I (275,000) 12,193 0 -
VCYT Veracyte, Inc. Director   –       •      –    2019-02-28 4 S $20.44 $7,176,400 I/I (350,000) 14,216 0 -
VCYT Veracyte, Inc. Director   –       •      –    2019-03-04 4 S $20.21 $8,632,722 I/I (427,151) 0 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2007-05-18 4 S $19.25 $486,005 I/I (25,247) 91,781 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-12-06 4/A S $16.75 $25,263,154 I/I (1,508,248) 112,200 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-12-06 4 S $16.75 $25,263,171 I/I (1,508,249) 112,200 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2007-05-17 4 S $14.50 $62,307 I/I (4,297) 15,082 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2008-07-16 4 S $14.49 $280,483 I/I (19,357) 62,513 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-11-27 4 S $14.27 $299,670 I/I (21,000) 83,975 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2007-06-05 4 S $14.07 $49,245 I/I (3,500) 11,582 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 B $14.00 $3,999,996 I/I 285,714 35,253 1.5 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2014-03-19 4 D $14.00 $146,195,434 I/I (10,442,531) 0 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •       •   2006-12-21 4 S $13.52 $87,326 I/I (6,459) 19,379 0 -
NSTR Northstar Neuroscience In... Director   –       •      –    2007-05-15 4 S $13.20 $5,002,800 I/I (379,000) 0 0 -
NSTR Northstar Neuroscience In... Director   –       •      –    2006-11-06 4 S $13.10 $164,143 I/I (12,530) 25,056 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •       •   2006-09-18 4 S $13.03 $84,161 I/I (6,459) 25,838 0 -
NSTR Northstar Neuroscience In... Director   –       •      –    2007-05-04 4 S $13.00 $207,623 I/I (15,971) 0 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2011-11-21 4 B $13.00 $12,111,879 I/I 931,683 51,013 1.5 -
VOLC Volcano Corp 10% Owner   –       –       •   2008-04-08 4 S $12.98 $218,479 I/I (16,832) 78,168 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 B $12.00 $6,300,000 I/I 525,000 104,975 1.5 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2007-06-06 4 S $11.26 $275,870 I/I (24,500) 73,575 0 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 D $11.00 $83,633 I/I (7,603) 1,744,013 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 B $11.00 $4,158,308 I/I 378,028 4,829,773 1.5 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed